Naturally occurring free thiols within β2-glycoprotein I in vivo: Nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury

Blood

Volumn 116, Issue 11, 2010, Pages 1961-1970

  Ioannou, Yiannis ^a,b   Zhang, Jing Yun ^a,c   Passam, Freda H ^a   Rahgozar, Soheila ^a   Qi, Jian Cheng ^a   Giannakopoulos, Bill ^a   Qi, Miao ^a   Yu, Pei ^a,c   Yu, Demin M ^c   Hogg, Philip J ^a   Krilis, Steven A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; ENDOPLASMIC RETICULUM PROTEIN 46; OXIDOREDUCTASE; PROTEIN DISULFIDE ISOMERASE; THIOL; THIOREDOXIN 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CELL DAMAGE; CELL PROTECTION; CELL SURFACE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NITROSYLATION; NONHUMAN; NORMAL HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE ADHESION;

EID: 77956903176     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-04-215335     Document Type: Article

References (46)

1. Holmgren A. Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid Redox Signal. 2000;2(4):811-820. (Pubitemid 32062330)
2. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol. 2002;4(10):743-749.
3. Foster MW, McMahon TJ, Stamler JS. S-nitrosylation in health and disease. Trends Mol Med. 2003;9(4):160-168.
4. Nakamura H, De Rosa SC, Yodoi J, et al. Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci U S A. 2001;98(5):2688-2693.
5. Nakamura H, Herzenberg LA, Bai J, et al. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci U S A. 2001;98(26):15143-15148.
6. Kakisaka Y, Nakashima T, Sumida Y, et al. Elevation of serum thioredoxin levels in patients with type 2 diabetes. Horm Metab Res. 2002;34(3):160-164.
7. Abdiu A, Nakamura H, Sahaf B, Yodoi J, Holmgren A, Rosen A. Thioredoxin blood level increases after severe burn injury. Antioxid Redox Signal. 2000;2(4):707-716. (Pubitemid 32062322)
8. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta. 2006;367(1-2):156-161.
9. Sato A, Hara T, Nakamura H, et al. Thioredoxin-1 suppresses systemic inflammatory responses against cigarette smoking. Antioxid Redox Signal. 2006;8(9-10):1891-1896.
10. Tsuji G, Koshiba M, Nakamura H, et al. Thioredoxin protects against joint destruction in a murine arthritis model. Free Radic Biol Med. 2006;40(10):1721-1731.
11. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690-1697.
12. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol. 2005;25(1):29-38.
13. Shi T, Giannakopoulos B, Yan X, et al. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum. 2006;54(8):2558-2567.
14. Pennings MTT, Derksen R, van Lummel M, Adelmeijer J, Lisman T, de Groot PG. Platelet adhesion to dimeric beta2-glycoprotein I under conditions of flow is mediated by glycoprotein Iba. J Thromb Haemost. 2007;5(2):369-377.
15. Lutters BC, Derksen RH, Tekelenburg WL, Lenting PJ, Arnout J, de Groot PG. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. J Biol Chem. 2003;278(36):33831-33838.
16. Zhang J, McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/antibeta2 glycoprotein I antibodies. Blood. 2005;105(5):1964-1969. (Pubitemid 40731779)
17. Reed JH, Giannakopoulos B, Jackson MW, Krilis SA, Gordon TP. Ro60 functions as a receptor for beta2-glycoprotein I on apoptotic cells. Arthritis Rheum. 2008;60(3):860-869.
18. Shi T, Iverson GM, Qi JC, et al. Beta 2-glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I. Proc Natl Acad Sci U S A. 2004;101(11):3939-3944.
19. Rahgozar S, Giannakopoulos B, Yan X, et al. Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies. Arthritis Rheum. 2008;58(4):1146-1155.
20. Maiti SN, Balasubramanian K, Ramoth JA, Schroit AJ. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J Biol Chem. 2008;283(7):3761-3766.
21. George J, Harats D, Gilburd B, et al. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation. 1999;99(17):2227- 2230.
22. Nojima J, Masuda Y, Iwatani Y, et al. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2008;47(5):684-689.
23. Delgado Alves J, Mason LJ, Ames PR, et al. Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model. Rheumatology (Oxford). 2005;44(10):1238-1244. (Pubitemid 41487956)
24. Giannakopoulos B, Passam F, Ioannou Y, Krilis SA. How we diagnose the antiphospholipid syndrome. Blood. 2009;113:985-994.
25. Bouma B, de Groot PG, van den Elsen JM, et al. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 1999;18(19):5166-5174.
26. Schwarzenbacher R, Zeth K, Diederichs K, et al. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 1999;18(22):6228-6239. (Pubitemid 29533227)
27. Yu P, Passam FH, Yu DM, Denyer G, Krilis S. β2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. J Thromb Haemost. 2008;6(7):1215-1223.
28. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor-VIII related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80:3734-3737.
29. Passam FH, Rahgozar S, Qi M, et al. Beta 2 glycoprotein I is a substrate of thiol oxidoreductases [letter]. Blood. 2010;116(11):1995-1997.
30. Katsoulotos GP, Qi M, Qi JC, et al. The Diacylglycerol- dependent translocation of ras guanine nucleotide-releasing protein 4 inside a human mast cell line results in substantial phenotypic changes, including expression of interleukin 13 receptor alpha2. J Biol Chem. 2008;283(3):1610-1621.
31. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol. 2001;3(2):193-197.
32. Sheng Y, Reddel SW, Herzog H, et al. Impaired thrombin generation in beta 2-glycoprotein I null mice. J Biol Chem. 2001;276(17):13817-13821. (Pubitemid 33657403)
33. Raschi E, Testoni C, Bosisio D, et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood. 2003;101(9):3495-3500.
34. Hotchkiss KA, Matthias LJ, Hogg PJ. Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase. Biochim Biophys Acta. 1998;1388(2):478-488.
35. Jasuja R, Furie B, Furie BC. Endothelial cell thiol isomerases: potential role in thrombus formation [abstract]. Blood. 2007;110(11):Abstract 3709.
36. Claise C, Edeas M, Chaouchi N, et al. Oxidized-LDL induce apoptosis in HUVEC but not in the endothelial cell line EA.hy 926. Atherosclerosis. 1999;147(1):95-104. (Pubitemid 29486778)
37. Stamler JS, Lamas S, Fang FC. Nitrosylation. the prototypic redox-based signaling mechanism. Cell. 2001;106(6):675-683.
38. Jordan PA, Gibbins JM. Extracellular disulfide exchange and the regulation of cellular function. Antioxid Redox Signal. 2006;8(3-4):312-324.
39. Jordan PA, Stevens JM, Hubbard GP, et al. A role for the thiol isomerase protein ERP5 in platelet function. Blood. 2005;105(4):1500-1507.
40. Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest. 2008;118(3):1123-1131. (Pubitemid 351364619)
41. Soderberg A, Sahaf B, Rosen A. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res. 2000;60:2281-2289.
42. Mannick JB, Schonhoff CM. Measurement of protein S-nitrosylation during cell signaling. Methods Enzymol. 2008;440:231-242.
43. Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005;6(2):150-166.
44. Passam FH, Rahgozar S, Qi M, et al. Redox control of beta 2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1. J Thromb Haemost. 2010;8(8):1754-1762.
45. Ahamed J, Versteeg HH, Kerver M, et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A. 2006;103(38):13932-13937.
46. Sullivan DC, Huminiecki L, Moore JW, et al. EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor. J Biol Chem. 2003;278(47):47079-47088.